Senior insider sale
Chief Financial Officer at LIFECORE BIOMEDICAL, INC. \DE\ — senior position signals high conviction
$665.0K
112.60K shares
MORBERG JOHN D plans to sell 112.60K shares of LIFECORE BIOMEDICAL, INC. \DE\ valued at approximately $665.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Bonus
N/A
RSUs
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/6/2024 | Bonus N/A | 4K | — |
9/26/2024 | RSUs N/A | 77.98K | — |
| Total | 81.98K | ||
Completed
Units to sell
30.99K
Market value
$205.8K
Units to sell
40.99K
Market value
$232.9K
Units to sell
5.19K
Market value
$25.6K
Units to sell
7.43K
Market value
$38.0K
Units to sell
12K
Market value
$60.7K
Units to sell
3K
Market value
$14.7K
Units to sell
3K
Market value
$15.5K
Planned — Approximate Date
Units to sell
10K
Market value
$71.7K
Units
112.60K
Value
$665.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/11/2024 | 30.99K | $205.8K | — | Completed |
10/31/2024 | 40.99K | $232.9K | — | Completed |
10/17/2024 | 5.19K | $25.6K | — | Completed |
10/7/2024 | 7.43K | $38.0K | — | Completed |
10/4/2024 | 12K | $60.7K | — | Completed |
10/2/2024 | 3K | $14.7K | — | Completed |
9/20/2024 | 3K | $15.5K | — | Completed |
| Planned — Approximate Date | ||||
11/20/2024 | 10K | $71.7K | Nasdaq | Planned |
| Total | 112.60K | $665.0K | ||